EUVIMEDEUVIMED entdecken
Crossref

Design and Evaluation of Biodegradable Self‐Immolative Lipids for RNA Delivery

Rajesh Mukthavaram, Amit Sagi, Hyojung Hong, River Recatto, Simon Chikamatsu, Angel Leu, Anna Shishina, Grishma Acharya, Thanhchau Dam, Ben Soontornniyomkij, Cristiano Sacchetti, Steven P Tanis und 3 weitere

Advanced Healthcare Materials · 2025-08 · 14 (22)

DOI: 10.1002/adhm.202501305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 16.06.2025. Verfasst von Rajesh Mukthavaram und 14 weiteren Autor:innen. Beteiligte Einrichtung: Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA, 92121, USA. Hauptthemen laut MEDLINE: Lipids, Nanoparticles, Gene Transfer Techniques, RNA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticle (LNP) is a proven platform for the safe and efficacious delivery of nucleic acid‐based therapeutics. Regulatory approvals of Patisiran, and mRNA vaccines against Covid‐19 are testaments to this fact. A key requisite for enabling a safe and biocompatible delivery system is the quick degradation and elimination of the various lipid components comprising the LNPs. Here, a new family of ionizable cationic lipids called “Self‐Immolative Lipids” (SILs) is reported. This innovative lipid architecture is designed to overcome a critical challenge in non‐viral gene therapy: the need for a delivery vector that is both efficacious and stable during biodistribution while remaining biodegradable upon reaching the target cell. These lipids demonstrate high stability in serum, required for the efficient delivery of the cargo, and an efficient bio‐degradation profile under the reducing conditions of the cytosol through a sequence of initial disulfide reduction and subsequent self‐elimination reactions resulting in the complete degradation of the lipids to facilitate elimination. These lipids demonstrated improved or equal activity and increased biodegradability compared to MC3, the ionizable lipid used in the first clinically approved LNP called Patisiran.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipidsNanoparticlesGene Transfer TechniquesRNAHumansAnimalsCOVID-19SARS-CoV-2MiceGenetic Therapy

Stichwörter der Autor:innen

glutathioneionizable lipidslipid nanoparticlesmRNA

Substanzen

LipidsRNA

Autor:innen und Institutionen

  • Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA, 92121, USA.
  • SPTanis PharmaChem Consulting LLC, 1750 Oriole Ct, Carlsbad, CA, 92011, USA.

ORCID-Profile: Kumar Rajappan

Zitieren

APA

Mukthavaram, R., Sagi, A., Hong, H., Recatto, R., Chikamatsu, S., Leu, A., Shishina, A., Acharya, G., Dam, T., Soontornniyomkij, B., Sacchetti, C., Tanis, S. P., Karmali, P. P., Rajappan, K., & Chivukula, P. (2025). Design and Evaluation of Biodegradable Self‐Immolative Lipids for RNA Delivery. Advanced Healthcare Materials, 14(22). https://doi.org/10.1002/adhm.202501305

Vancouver

Mukthavaram R, Sagi A, Hong H, Recatto R, Chikamatsu S, Leu A, et al. Design and Evaluation of Biodegradable Self‐Immolative Lipids for RNA Delivery. Advanced Healthcare Materials. 2025;14(22). doi:10.1002/adhm.202501305

BibTeX
@article{Mukthavaram2025,
  author = {Mukthavaram, Rajesh and Sagi, Amit and Hong, Hyojung and Recatto, River and Chikamatsu, Simon and Leu, Angel and Shishina, Anna and Acharya, Grishma and Dam, Thanhchau and Soontornniyomkij, Ben and Sacchetti, Cristiano and Tanis, Steven P and Karmali, Priya P and Rajappan, Kumar and Chivukula, Padmanabh},
  title = {Design and Evaluation of Biodegradable Self‐Immolative Lipids for RNA Delivery},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {22},
  doi = {10.1002/adhm.202501305}
}
Kostenlos starten →